ArticleRheumatology and therapy2020

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.